# Kimco Realty Corp: financial statements, quarterly

KIM · NYSE · CIK 879101 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kim.md) · [Financials](/companies/kim/financials.md) · [Filings](/companies/kim/filings.md) · [Insiders](/companies/kim/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kim/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [446](/filings/0000950170-24-119432.md) | [452 d](/filings/0001193125-26-060760.md) | [504](/filings/0000950170-25-062383.md) | [500](/filings/0000950170-25-101195.md) | [508](/filings/0001193125-25-258133.md) | [525 d](/filings/0001193125-26-060760.md) | [537](/filings/0001193125-26-195304.md) | [525](/filings/0001193125-26-331817.md) | [536](/filings/0001193125-25-258133.md) | [542 d](/filings/0001193125-26-060760.md) | [558](/filings/0001193125-26-195304.md) | [551](/filings/0001193125-26-331817.md) |
| Operating income | $m | [141](/filings/0000950170-24-119432.md) | [169 d](/filings/0001193125-26-060760.md) | [131](/filings/0000950170-25-062383.md) | [161](/filings/0000950170-25-101195.md) | [171](/filings/0001193125-25-258133.md) | [166 d](/filings/0001193125-26-060760.md) | [180](/filings/0001193125-26-195304.md) | [206](/filings/0001193125-26-331817.md) | [187](/filings/0001193125-25-258133.md) | [197 d](/filings/0001193125-26-060760.md) | [208](/filings/0001193125-26-195304.md) | [196](/filings/0001193125-26-331817.md) |
| Interest expense | $m | [60.4](/filings/0000950170-24-119432.md) | [67.8 d](/filings/0001193125-26-060760.md) | [74.6](/filings/0000950170-25-062383.md) | [73.3](/filings/0000950170-25-101195.md) | [76.2](/filings/0001193125-25-258133.md) | [83.7 d](/filings/0001193125-26-060760.md) | [80.4](/filings/0001193125-26-195304.md) | [81.2](/filings/0001193125-26-331817.md) | [84.3](/filings/0001193125-25-258133.md) | [84.4 d](/filings/0001193125-26-060760.md) | [83.1](/filings/0001193125-26-195304.md) | [83.9](/filings/0001193125-26-331817.md) |
| Income tax | $m | [(0.7)](/filings/0000950170-24-119432.md) | [(0.2) d](/filings/0001193125-26-060760.md) | [72.0](/filings/0000950170-25-062383.md) | [0.2](/filings/0000950170-25-101195.md) | [0.1](/filings/0001193125-25-258133.md) | [(46.9) d](/filings/0001193125-26-060760.md) | [0.5](/filings/0001193125-26-195304.md) | [0.4](/filings/0001193125-26-331817.md) | [(0.9)](/filings/0001193125-25-258133.md) | [1.1 d](/filings/0001193125-26-060760.md) | [(0.2)](/filings/0001193125-26-195304.md) | [0.0](/filings/0001193125-26-331817.md) |
| Net income | $m | [118](/filings/0000950170-24-119432.md) | [140 d](/filings/0001193125-26-060760.md) | [(11.0)](/filings/0000950170-25-062383.md) | [120](/filings/0000950170-25-101195.md) | [136](/filings/0001193125-25-258133.md) | [166 d](/filings/0001193125-26-060760.md) | [133](/filings/0001193125-26-195304.md) | [163](/filings/0001193125-26-331817.md) | [138](/filings/0001193125-25-258133.md) | [151 d](/filings/0001193125-26-060760.md) | [165](/filings/0001193125-26-195304.md) | [153](/filings/0001193125-26-331817.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001437749-23-029222.md) | [0.8](/filings/0000950170-25-024723.md) | [0.1](/filings/0001437749-24-016080.md) | [0.1](/filings/0000950170-24-089760.md) | [0.8](/filings/0000950170-24-119432.md) | [0.7](/filings/0001193125-26-060760.md) | [0.1](/filings/0000950170-25-062383.md) | [0.2](/filings/0000950170-25-101195.md) | [0.2](/filings/0001193125-25-258133.md) | [0.2](/filings/0001193125-26-331817.md) | [0.2](/filings/0001193125-26-195304.md) | [0.7](/filings/0001193125-26-331817.md) |
| Total assets | $bn | [18.0](/filings/0001437749-23-029222.md) | [18.3](/filings/0000950170-25-024723.md) | [19.5](/filings/0001437749-24-016080.md) | [19.5](/filings/0000950170-24-089760.md) | [20.1](/filings/0000950170-24-119432.md) | [20.3](/filings/0001193125-26-060760.md) | [19.7](/filings/0000950170-25-062383.md) | [19.8](/filings/0000950170-25-101195.md) | [19.9](/filings/0001193125-25-258133.md) | [19.7](/filings/0001193125-26-331817.md) | [19.6](/filings/0001193125-26-195304.md) | [20.0](/filings/0001193125-26-331817.md) |
| Total liabilities | $bn | [8.1](/filings/0001437749-23-029222.md) | [8.5](/filings/0000950170-25-024723.md) | [8.6](/filings/0001437749-24-016080.md) | [8.7](/filings/0000950170-24-089760.md) | [9.4](/filings/0000950170-24-119432.md) | [9.5](/filings/0001193125-26-060760.md) | [9.0](/filings/0000950170-25-062383.md) | [9.1](/filings/0000950170-25-101195.md) | [9.2](/filings/0001193125-25-258133.md) | [9.1](/filings/0001193125-26-331817.md) | [9.0](/filings/0001193125-26-195304.md) | [9.6](/filings/0001193125-26-331817.md) |
| Long-term debt | $bn | not reported | [7.3](/filings/0000950170-25-024723.md) | not reported | not reported | not reported | [8.0](/filings/0001193125-26-060760.md) | not reported | not reported | not reported | [7.7](/filings/0001193125-26-060760.md) | not reported | not reported |
| Shareholders' equity | $bn | [9.6](/filings/0001437749-23-029222.md) | [9.5](/filings/0000950170-25-024723.md) | [10.6](/filings/0001437749-24-016080.md) | [10.6](/filings/0000950170-24-089760.md) | [10.5](/filings/0000950170-24-119432.md) | [10.7](/filings/0001193125-26-060760.md) | [10.6](/filings/0000950170-25-062383.md) | [10.5](/filings/0000950170-25-101195.md) | [10.5](/filings/0001193125-25-258133.md) | [10.4](/filings/0001193125-26-331817.md) | [10.4](/filings/0001193125-26-195304.md) | [10.3](/filings/0001193125-26-331817.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [281 d](/filings/0000950170-24-119432.md) | [190 d](/filings/0001193125-26-060760.md) | [176](/filings/0000950170-25-062383.md) | [294 d](/filings/0000950170-25-101195.md) | [296 d](/filings/0001193125-25-258133.md) | [240 d](/filings/0001193125-26-060760.md) | [224](/filings/0001193125-26-195304.md) | [305 d](/filings/0001193125-26-331817.md) | [332 d](/filings/0001193125-25-258133.md) | [258 d](/filings/0001193125-26-060760.md) | [243](/filings/0001193125-26-195304.md) | [345 d](/filings/0001193125-26-331817.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | [18.4](/filings/0001193125-26-195304.md) | [0.0 d](/filings/0001193125-26-331817.md) | [0.0 d](/filings/0001193125-25-258133.md) | [0.0 d](/filings/0001193125-26-060760.md) | not reported | not reported |
| Dividends paid | $m | [149 d](/filings/0000950170-24-119432.md) | [211 d](/filings/0001437749-24-005407.md) | [168](/filings/0001437749-24-016080.md) | [170 d](/filings/0000950170-24-089760.md) | [170 d](/filings/0000950170-24-119432.md) | [175 d](/filings/0001193125-26-060760.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-258133.md) | [0.0 d](/filings/0001193125-26-060760.md) | [0.0](/filings/0001193125-26-195304.md) | [58.8 d](/filings/0001193125-26-331817.md) | [0.0 d](/filings/0001193125-25-258133.md) | [61.5 d](/filings/0001193125-26-060760.md) | [0.5](/filings/0001193125-26-195304.md) | [105 d](/filings/0001193125-26-331817.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [618](/filings/0001437749-23-029222.md) | [620](/filings/0001437749-24-016080.md) | [617](/filings/0000950170-24-089760.md) | [617](/filings/0000950170-24-119432.md) | [670](/filings/0000950170-25-062383.md) | [671](/filings/0000950170-25-101195.md) | [672](/filings/0001193125-25-258133.md) | [677](/filings/0001193125-26-195304.md) | [675](/filings/0001193125-26-331817.md) | [675](/filings/0001193125-25-258133.md) | [673](/filings/0001193125-26-195304.md) | [672](/filings/0001193125-26-331817.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 670,789,373 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-331817.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.